Protagonist Therapeutics (PTGX) Asset Utilization Ratio (2018 - 2026)

Protagonist Therapeutics (PTGX) has 9 years of Asset Utilization Ratio data on file, last reported at 0.11 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio fell 60.11% year-over-year to 0.11; the trailing twelve-month figure through Mar 2026 stood at 0.11 (down 60.11% YoY), and the FY2025 full-year result was 0.07, down 91.73% from the prior year.
• Asset Utilization Ratio rose to 0.11 in Q1 2026, from 0.07 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.64 in Q4 2024 to a low of 0.0 in Q1 2023.
• A 5-year average of 0.26 and a median of 0.15 in 2023 frame the typical range for Asset Utilization Ratio.
• Across the five-year window, Asset Utilization Ratio tumbled 97.39% in 2023 and soared 17440.91% in 2024, its largest moves.
• Tracing PTGX's Asset Utilization Ratio over 5 years: stood at 0.1 in 2022, then soared by 44.94% to 0.15 in 2023, then surged by 337.49% to 0.64 in 2024, then sank by 89.44% to 0.07 in 2025, then surged by 61.45% to 0.11 in 2026.
• Business Quant data shows PTGX's Asset Utilization Ratio at 0.11 in Q1 2026, 0.07 in Q4 2025, and 0.29 in Q3 2025.